Idexx Laboratories (IDXX) Consolidated Net Income (2009 - 2026)
Idexx Laboratories' Consolidated Net Income came in at $338.41 million for Q2 2026, up 15.1% from $293.99 million a year earlier and up 21.5% from the prior quarter.
Idexx Laboratories (IDXX) Consolidated Net Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Idexx Laboratories reported Consolidated Net Income of $1.14 billion, up 15.6% year-over-year; for FY2025, it came in at $1.06 billion, up 19.3% from FY2024.
- Consolidated Net Income has increased in each of the last three years, with a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- Going back by year, Consolidated Net Income was $887.87 million in FY2024 (+5.1%), $845.04 million in FY2023 (+24.4%), $679.09 million in FY2022 (-8.8%) and $744.84 million in FY2021 (+28.0%).
- The Q2 2026 figure represents the highest quarterly Consolidated Net Income in data going back to Q2 2009.
- Year-over-year, Consolidated Net Income has increased for eight consecutive quarters, with growth averaging 16.4% over the last eight quarters.
- The fastest year-over-year change in Consolidated Net Income over five years came in Q2 2023 (growth of 69.9%), and the weakest in Q2 2022 (a decline of 34.9%).
- Business Quant data shows IDXX's Consolidated Net Income at $278.45 million (Q1 2026), $248.19 million (Q4 2025) and $274.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Idexx Laboratories | 40.86 Bn | 40.07 Bn | 779.09 Mn | 338.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 338.41 Mn |
| Mar 31, 2026 | 278.45 Mn |
| Dec 31, 2025 | 248.19 Mn |
| Sep 30, 2025 | 274.61 Mn |
| Jun 30, 2025 | 293.99 Mn |
| Mar 31, 2025 | 242.68 Mn |
| Dec 31, 2024 | 216.15 Mn |
| Sep 30, 2024 | 232.84 Mn |
| Jun 30, 2024 | 203.30 Mn |
| Mar 31, 2024 | 235.58 Mn |
| Dec 31, 2023 | 194.52 Mn |
| Sep 30, 2023 | 212.23 Mn |
| Jun 30, 2023 | 224.24 Mn |
| Mar 31, 2023 | 214.05 Mn |
| Dec 31, 2022 | 172.21 Mn |
| Sep 30, 2022 | 180.94 Mn |
| Jun 30, 2022 | 131.98 Mn |
| Mar 31, 2022 | 193.97 Mn |
| Dec 31, 2021 | 162.77 Mn |
| Sep 30, 2021 | 175.18 Mn |
Idexx Laboratories Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=IDXX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();